-
ICD-10-CM Codes
›
-
C00-D49
›
-
D00-D09
›
-
D07-
›
-
2023 ICD-10-CM Diagnosis Code D07.4
2023 ICD-10-CM Diagnosis Code D07.4
Carcinoma in situ of penis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Male Dx
- D07.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D07.4 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D07.4 - other international versions of ICD-10 D07.4 may differ.
ICD-10-CM Coding Rules
- D07.4 is applicable to male patients.
Applicable To- Erythroplasia of Queyrat NOS
The following code(s) above
D07.4 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D07.4:
- C00-D49
2023 ICD-10-CM Range C00-D49
NeoplasmsNote- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
- D00-D09
2023 ICD-10-CM Range D00-D09
In situ neoplasmsIncludes- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
- D07
ICD-10-CM Diagnosis Code D07
Carcinoma in situ of other and unspecified genital organs
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- melanoma in situ of trunk (D03.5)
- Bowen's disease of penis
- Bowens disease of penis
- Cancer in situ of penis
- Erythroplasia, queyrats
- Queyrat's erythroplasia
Clinical Information
- Abnormal cells are found on the surface of the skin of the penis. These abnormal cells may become cancer and spread into nearby normal tissue.
- Stage 0 includes: (tis, n0, m0) and (ta, n0, m0). Tis: carcinoma in situ. Ta: non-invasive verrucous carcinoma. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th ed.)
- Stage 0 includes: tis, n0, m0. Tis: carcinoma in situ. Cn0: no palpable or visibly enlarged inguinal lymph nodes. Pn0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 7th ed.)
ICD-10-CM D07.4 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 715 Other male reproductive system o.r. Procedures for malignancy with cc/mcc
- 716 Other male reproductive system o.r. Procedures for malignancy without cc/mcc
- 722 Malignancy, male reproductive system with mcc
- 723 Malignancy, male reproductive system with cc
- 724 Malignancy, male reproductive system without cc/mcc
Convert D07.4 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D07.4:
ICD-10-CM Codes Adjacent To D07.4
D06.1 Carcinoma in situ of exocervix
D06.7 Carcinoma in situ of other parts of cervix
D06.9 Carcinoma in situ of cervix, unspecified
D07 Carcinoma in situ of other and unspecified genital organs
D07.0 Carcinoma in situ of endometrium
D07.1 Carcinoma in situ of vulva
D07.2 Carcinoma in situ of vagina
D07.3 Carcinoma in situ of other and unspecified female genital organs
D07.30 Carcinoma in situ of unspecified female genital organs
D07.39 Carcinoma in situ of other female genital organs
D07.4
Carcinoma in situ of penis
D07.5 Carcinoma in situ of prostate
D07.6 Carcinoma in situ of other and unspecified male genital organs
D07.60 Carcinoma in situ of unspecified male genital organs
D07.61 Carcinoma in situ of scrotum
D07.69 Carcinoma in situ of other male genital organs
D09 Carcinoma in situ of other and unspecified sites
D09.0 Carcinoma in situ of bladder
D09.1 Carcinoma in situ of other and unspecified urinary organs
D09.10 Carcinoma in situ of unspecified urinary organ
D09.19 Carcinoma in situ of other urinary organs
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
